'a complete solution from GMP laboratories to GMP manufacturing'
At our Reading facility we offer full cGMP manufacturing to support phase 1 and phase 2 clinical trials in reactors up to 50 L and operating at temperatures from minus 90 oC to 200 oC. Late phase and commercial production is available at our cGMP facility in New Zealand.
cGMP manufacture is supported by a full analytical capability that includes method development, qualification and validation as well as degradation and stability studies, specification development and full QC testing of all incoming raw materials and intermediates. Our analytical facilities are resourced with qualified equipment which allows us to support all phases of our projects.
See www.nzp.co.nz for large-scale synthesis and other manufacturing capabilities.